Clinical Trial Update: Teriparatide (PTH) and Bone Strength in Postmenopausal Women

View source ↗

Summary

This clinical trial update discusses the use of teriparatide (PTH) to assess bone strength in postmenopausal women with osteoporosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis

Drugs mentioned

• Teriparatide (PTH) (teriparatide)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Osteoporosis | Status: UNKNOWN